--(BUSINESS WIRE)--Canines-N-Kids Foundation:
Canines-N-Kids Foundation, a nonprofit committed to finding a cure to the devastating cancers that canines and children both develop, is hosting the first Paws for a Cure Summit. With a significant grant from the Petco Foundation in conjunction with the Blue Buffalo Foundation, the event is convening the foremost leaders and researchers in veterinary and pediatric oncology, immunology and translational science, industry and the advocacy community with a goal of developing a pathway to innovative pediatric cancer treatments that may also help man’s best friend. The sessions will explore: how canine cancers represent in their human counterparts; unique challenges scientists face in studying canine cancers; the state of conducting canine trials; gaps in pediatric oncology that can be addressed through the canine model; innovative comparative work ongoing; advocating for both pet and pediatric patients; and developing a roadmap for integrated drug development. The V Foundation for Cancer Research (Cary, NC) and the Quad W Foundation (Dallas, Texas) are also Summit sponsors.
- Ulrike Szalay, Founder, Canines-N-Kids
- Dr. William Eward, Duke Cancer Institute
- Dr. Matthew Breen, NC State School of Veterinary Medicine
- Dr. Amy LeBlanc, Director of the Comparative Oncology Trials Group, NCI
- Dr. Josh Schiffman, MD Huntsman Cancer Center
- Dr. Carol Roberston-Plouch, Eli Lilly
- Dr. Len Lichtenfeld, Deputy Chief Medical Officer, American Cancer Society
- Susan Braun, CEO, V Foundation
- Barbara Cohen, Executive Director, Animal Cancer Foundation
- Dr. Chand Khanna, Ethos Discovery
- Dr. Damon Reed, Sunshine Foundation
- Arlene Weintraub, Author of Heal, health/biotech reporter (Forbes, Fierce Biotech)
- Susanne Kogut, Executive Director, Petco Foundation
- Dr. Greg Aune, childhood cancer survivor and Pediatric Oncologist, Cancer Researcher, Greehey Children’s Cancer Research Hospital San Antonio
- Dr. Nicola Mason, Veterinarian and Immunologist who oversees several comparative canine cancer immunotherapy trials, Penn’s School of Veterinary Medicine
June 12, 2017, 8:30am-5pm
National Press Club
529 14th St NW, Washington, DC
More than 16,000 children and 6 million dogs get diagnosed with cancer each year. The problems inherent in designing and implementing pediatric oncology clinical trials coupled with scant resources makes finding a cure difficult. In fact, only three new medicines have been developed for pediatric cancer in the last 30 years, only 4% of the NIH’s budget goes to kids’ cancer and virtually no pharmaceutical funding goes to pediatric cancer research. For dogs diagnosed with cancer, the outlook is no better. Comparative oncology, the study of similar cancers that occur in animals and people, offers tremendous opportunity to find treatments that will benefit both.
Contact Shawn Flaherty at 703-554-3609 to cover the summit.